Bridgewater Chapter Upcoming Events Join PCCI

 

MBF Therapeutics

A leader in gene-based checkpoint inhibitor therapies

Presenter: Tom Tillett

 

Monday, March 9, 2020

Embassy Suites, Chesterbrook, Pennsylvania (directions)

 

About

 

MBF Therapeutics is a clinical-stage animal health company focused on the development of gene-based, immunotherapeutic vaccines for use in veterinary medicine.  It uses a proprietary vaccine platform and delivery system technology called "checkpoint inhibitor therapies".  These have the potential of transforming the treatment of cancer and prevention of infectious diseases in both companion animals and livestock.

 

MBF Therapeutics’ lead product is an immunotherapeutic vaccine for canine melanoma. Two pilot studies have been completed:  

  •     The vaccine was shown to be safe
  •     It elicited a robust immune response in 100% of dogs treated
  •     It has potential for a conditional registration as early as 2020

MBF Therapeutics also has a strong pipeline of products, including vaccines for other cancers in companion animals, as well as economically significant infectious swine diseases.

 

 

3 Major Issues

 

  1. How do we get life science investors who have never seen an animal health opportunity to invest in this company? 
  2. If we are correct that we can “turbo-charge” both B-cell and T-cell responses in a sustainable process, this is truly disruptive technology.  What are our greatest risks in introducing disruptive technology? 
  3. Please give us your opinion on these exit strategies for investors:
      -  Build an animal health company, then sell it, but retain human health rights
      -  Sell certain rights (cattle, poultry, etc.) and share proceeds with investors
      -  Go for an IPO.  Or do a reverse merger IPO.

 

 

Program:

 

6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet me nu)

7:45 - Tom Tillett, CEO of MBF Therapeutics, will deliver "Elevator" Pitch to the Group

8:00 - A Panel will address three major issues crucial to helping the Company reach the next level.

9:00 - Open discussion: members and guests

 

 


Reservation

 

Reserve your spot for this special event online now though PayPal.

Please note: You do not need a PayPal account to reserve your spot, most credit cards are accepted.

 

Available Media

Please note: All information obtained here is the property of those presenting and should not be copied or duplicated without written consent.

 

Slides

None available at this time

Audio

None available at this time

Video

None available at this time

Webcast

None available at this time

 

The webcast recording of the PCCI meeting is posted on the PCCI website a few days after the event.

Contact Info:

 

 

Our Sponsors

KEH Insurance Agency
New Jersey Innovation Institute Science CenterWhite and Williams

 

<Top of the page>

 

 

 

 

Questions or Coments?

Contact: Peter van der Kam,

peter@rxpcci.com | (610) 296-8086

 

 

 

Good Company! Good Drink! Good Food! Good Program! Good Fun!

 

Site Navigation

HOME  |  ABOUT PCCI  |   DIRECTIONS  |   BRIDGEWATER DIRECTIONS  |   JOIN US  |   BOARD MEMBERS  |   AFFILIATES  |  NEXT MEETING  |  ARCHIVES

PROFILES CALENDAR OF EVENTS  |  BRIDGEWATER CHAPTER  |  FEEDBACK / COMMENTS  |   CONTACT US

Pharmaceutical Consulting Consortium International, Inc.,

info@rxpcci.com or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2018

 

 

Tat Communication Inc